1. Hepatocellular carcinoma and miRNAs: An in silico approach revealing potential therapeutic targets for polyphenols
   Luiz Gustavo de Almeida Chuffa et al, 2022, Phytomedicine Plus CrossRef
2. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma
   Francesco Vasuri et al, 2018, World Journal of Gastroenterology CrossRef
3. MiR-33a plays a crucial role in the proliferation of bovine preadipocytes
   Wenzhen Zhang et al, 2021, Adipocyte CrossRef
4. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1
   Dan Wu et al, 2022, Cancer Communications CrossRef
5. Role of microRNAs in hepatocellular cancer pathogenesis and prognosis
   Deepika Sarvepalli et al, 2022, Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma CrossRef
6. ssc-miR-185 targets cell division cycle 42 and promotes the proliferation of intestinal porcine epithelial cell
   Wei Wang et al, 2021, Animal Bioscience CrossRef
7. miR-33a-5p enhances the sensitivity of lung adenocarcinoma cells to celastrol by regulating mTOR signaling
   You-Jie Li et al, 2018, International Journal of Oncology CrossRef
8. microRNAs: Key players in virus‐associated hepatocellular carcinoma
   Javid Sadri Nahand et al, 2019, Journal of Cellular Physiology CrossRef
9. MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities
   Khadijeh Mahboobnia et al, 2024, International Journal of Molecular Sciences CrossRef
10. PNMA1, regulated by miR-33a-5p, promotes proliferation and EMT in hepatocellular carcinoma by activating the Wnt/β-catenin pathway
    Pengpeng Liu et al, 2018, Biomedicine & Pharmacotherapy CrossRef
11. Role of microRNA‑33a in malignant cells (Review)
    Chang Gao et al, 2020, Oncology Letters CrossRef
12. PPAR‐γ: Its ligand and its regulation by microRNAs
    Parvaneh Seiri et al, 2019, Journal of Cellular Biochemistry CrossRef
13. In vitro study on antioxidant and lipid-lowering activities of tobacco polysaccharides
    Shuaishuai Chang et al, 2024, Bioresources and Bioprocessing CrossRef
14. MicroRNA dysregulation interplay with childhood abdominal tumors
    Karina Bezerra Salomão et al, 2019, Cancer and Metastasis Reviews CrossRef
15. The Role of Extracellular Vesicles as Shuttles of RNA and Their Clinical Significance as Biomarkers in Hepatocellular Carcinoma
    Eva Costanzi et al, 2021, Genes CrossRef
16. APE1 controls DICER1 expression in NSCLC through miR-33a and miR-130b
    Giulia Antoniali et al, 2022, Cellular and Molecular Life Sciences CrossRef
17. Hepatocellular Carcinoma: The Role of MicroRNAs
    Sharad Khare et al, 2022, Biomolecules CrossRef
18. Six genes as potential diagnosis and prognosis biomarkers for hepatocellular carcinoma through data mining
    Yaqiong Zhang et al, 2019, Journal of Cellular Physiology CrossRef
19. The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC
    Ioana Rusu et al, 2022, International Journal of Molecular Sciences CrossRef
20. Knockdown expression of MECR, a novel gene of mitochondrial FAS II inhibits growth and colony-formation, promotes apoptosis of hepatocelluar carcinoma cells
    Yulong Cai et al, 2019, BioScience Trends CrossRef
21. Genome-Wide Methylation Profiling in Canine Mammary Tumor Reveals miRNA Candidates Associated with Human Breast Cancer
    Su-Jin Jeong et al, 2019, Cancers CrossRef